Pneumococcal Polysaccharide Serotype 14 Uses, Dosage, Side Effects and more
Pneumococcal Polysaccharide Serotype 14 is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 14 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
| Attribute | Details |
|---|---|
| Trade Name | Pneumococcal Polysaccharide Serotype 14 |
| Generic | Streptococcus pneumoniae type 14 capsular polysaccharide antigen |
| Streptococcus pneumoniae type 14 capsular polysaccharide antigen Other Names | pneumococcal capsular polysaccharide type 14 vaccine, Pneumococcal polysaccharide serotype 14 |
| Type | |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
